Biopharmaceutical Production Freeze Dryer

Biopharmaceutical Production Freeze Dryer – QualiFD™ BP Series Application

• Vaccines: Vaccine formulations often require low residual moisture to support stability in storage and transport. Freeze drying helps maintain structure and activity by avoiding high-temperature drying stress. Production control and batch documentation also support consistent release criteria.
• Pharmaceuticals and biopharmaceuticals: Many injectable and sterile products use lyophilization to extend shelf life and support cold-chain flexibility. A production Freeze Dryer supports recipe-based cycles for freezing, primary drying, and secondary drying. Integrated CIP/SIP options can support hygienic changeover expectations between campaigns.
• Biochemical drugs, biologics, and probiotics: Biologics and probiotic materials can be sensitive to heat and moisture. Freeze drying can reduce moisture while protecting structure, with vacuum and shelf temperature setpoints tuned to product limits. Cycle repeatability supports lot-to-lot consistency during scale-up.
• Extracts and nutritional supplements: Plant extracts and nutrition ingredients may be freeze-dried to protect aroma and reduce degradation pathways linked to water. Controlled drying helps keep powder behavior consistent for blending and filling. Data logging supports process troubleshooting when raw material variation appears.
• Diagnostic reagents and blood products: Moisture control is a common driver for diagnostic reagent stability and long-term storage performance. Freeze drying supports storage-friendly formats for sensitive reagents and related products. Process traceability supports investigations when field performance deviates from expectations.

Standards

• ISO 13408-3 (Aseptic processing — Lyophilization): requirements and guidance for controlling and validating lyophilization as an aseptic process.
• ISO 13408-4 (Clean-in-place technologies): requirements and guidance for CIP qualification, validation, operation, and control.
• ISO 13408-5 (Sterilization in place): requirements and guidance for SIP validation and routine control.
• ASTM E2500 (Specification, design, and verification of pharma/biopharma manufacturing systems and equipment): risk-based approach for verification and documentation.